CHARLES M BAUM Insider Trading
Get free email notifications about insider trading for CHARLES M BAUM.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of CHARLES M BAUM. CHARLES M BAUM is a Director in IMMUNOMEDICS INC ($IMMU) and a in ARRAY BIOPHARMA INC ($ARRY) and a Director in ARRAY BIOPHARMA INC ($ARRY) and a President & CEO in Mirati Therapeutics, Inc. ($MYG) and a President and CEO in Mirati Therapeutics, Inc. ($MYG) and a Director in PMV Pharmaceuticals, Inc. ($PMVP).
Address: 9363 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO 92121 CA
Companies in which CHARLES M BAUM is an Insider
ARRAY BIOPHARMA INC
Trading Symbol: ARRYIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of CHARLES M BAUM: Director
Holdings: 5,000 shares
Current Value: $52,650
Latest Transaction: Jul 30 2019
$ARRY Market Capitalization: $1.80B
$ARRY Previous Close: $10.53
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
IMMUNOMEDICS INC
Trading Symbol: IMMUIndustry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of CHARLES M BAUM: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Oct 23 2020
$IMMU Market Capitalization: $442.84M
$IMMU Previous Close: $4.23
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Mirati Therapeutics, Inc.
Trading Symbol: MYGIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of CHARLES M BAUM: President & CEO, President and CEO
Holdings: 152,714 shares
Latest Transaction: Jun 21 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
PMV Pharmaceuticals, Inc.
Trading Symbol: PMVPIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of CHARLES M BAUM: Director
Holdings: 0 shares
Latest Transaction: Apr 07 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of CHARLES M BAUM
Sentiment: All, ARRY, IMMU, MYG, PMVP
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 21 2021 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Option Exercise | M | 8.49 | 40,000 | 339,600 | 47,204 | |
Jun 21 2021 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Sell | S | 166.73 | 1,023 | 170,566 | 112,714 | 113.7 K to 112.7 K (-0.90 %) |
Jun 21 2021 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Sell | S | 166.07 | 20,823 | 3,457,986 | 113,737 | 134.6 K to 113.7 K (-15.47 %) |
Jun 21 2021 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Sell | S | 164.91 | 13,338 | 2,199,499 | 134,560 | 147.9 K to 134.6 K (-9.02 %) |
Jun 21 2021 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Sell | S | 164.07 | 4,816 | 790,182 | 147,898 | 152.7 K to 147.9 K (-3.15 %) |
Jun 21 2021 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Buy | M | 8.49 | 40,000 | 339,600 | 152,714 | 112.7 K to 152.7 K (+35.49 %) |
Apr 07 2021 | PMVP | PMV Pharmaceutical ... | BAUM CHARLES M | Director | Option Exercise | A | 34.11 | 32,677 | 1,114,612 | 32,677 |